Objective: To describe divergence between actionable statements issued by COVID-19 guideline developers catalogued on the "COVID-19 Recommendations and Gateway to Contextualization" platform. Study design and setting: We defined divergence as at least two comparable actionable statements with different explicit judgements of strength, direction or subgroup consideration of the population or intervention. We applied content analysis to compare guideline development methods for a sample of diverging statements and to evaluate factors associated with divergence. Results: Of the 138 guidelines evaluated, 85 (62%) contained at least one statement that diverged from another guideline. We identified 223 diverging statements in these 85 guidelines. We grouped statements into 66 clusters. Each cluster addressed the same population, intervention, and comparator group or just similar interventions. Clinical practice statements were more likely to diverge in explicit judgment of strength or direction compared to public health statements (Cramer's V = 0.7, Fisher's exact test; P <0.001). Statements were more likely to diverge in strength than direction. Date of publication, utilized evidence, interpretation of evidence, and contextualization considerations were associated with divergence. Conclusion: More than half of the assessed guidelines issued at least one diverging statement. This study helps understanding the types of differences between guidelines issuing comparable statements and factors associated with their divergence.

An evaluation of the eCOVID19 Recommendation Map identified diverging Clinical and Public Health guidance / Z.H. Nasir, D. Mertz, R. Nieuwlaat, N. Santesso, T. Lotfi, A. Motilall, L. Moja, L. Mbuagbaw, M. Klugar, A.F. Turgeon, J.L. Mathew, C. Canelo-Aybar, K. Pottie, O. Dewidar, M.W. Langendam, A. Iorio, G.E. Vist, J.J. Meerpohl, S. Flottorp, T. Kredo, T. Piggott, M. Mathews, A. Qaseem, D.K. Chu, P. Tugwell, J. Klugarová, H. Nelson, H. Hussein, J. Suvada, I. Neumann, H.J. Schünemann. - In: JOURNAL OF CLINICAL EPIDEMIOLOGY. - ISSN 0895-4356. - (2022 Mar 23). [Epub ahead of print] [10.1016/j.jclinepi.2022.03.008]

An evaluation of the eCOVID19 Recommendation Map identified diverging Clinical and Public Health guidance

L. Moja;
2022

Abstract

Objective: To describe divergence between actionable statements issued by COVID-19 guideline developers catalogued on the "COVID-19 Recommendations and Gateway to Contextualization" platform. Study design and setting: We defined divergence as at least two comparable actionable statements with different explicit judgements of strength, direction or subgroup consideration of the population or intervention. We applied content analysis to compare guideline development methods for a sample of diverging statements and to evaluate factors associated with divergence. Results: Of the 138 guidelines evaluated, 85 (62%) contained at least one statement that diverged from another guideline. We identified 223 diverging statements in these 85 guidelines. We grouped statements into 66 clusters. Each cluster addressed the same population, intervention, and comparator group or just similar interventions. Clinical practice statements were more likely to diverge in explicit judgment of strength or direction compared to public health statements (Cramer's V = 0.7, Fisher's exact test; P <0.001). Statements were more likely to diverge in strength than direction. Date of publication, utilized evidence, interpretation of evidence, and contextualization considerations were associated with divergence. Conclusion: More than half of the assessed guidelines issued at least one diverging statement. This study helps understanding the types of differences between guidelines issuing comparable statements and factors associated with their divergence.
COVID-19; Discordance; Divergence; GRADE; Guidelines; Recommendations;
Settore MED/42 - Igiene Generale e Applicata
23-mar-2022
Article (author)
File in questo prodotto:
File Dimensione Formato  
An evaluation of the eCOVID19 Recommendation Map.pdf

Open Access dal 02/07/2023

Tipologia: Post-print, accepted manuscript ecc. (versione accettata dall'editore)
Dimensione 1.24 MB
Formato Adobe PDF
1.24 MB Adobe PDF Visualizza/Apri
1-s2.0-S0895435622000695-main.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 683.32 kB
Formato Adobe PDF
683.32 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/923630
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 3
  • ???jsp.display-item.citation.isi??? 2
social impact